Pegloticase
Overview
Categories
- 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Pegloticase's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 8 to 8 mg | 8 (8) | As recommended. | IV | Pegloticase should be administered Every 2 weeks.
Dilute solution Pegloticase to reach Room Temperature.
Donot institute Pegloticase therapy with oral urate lowering agents.
donot Administer as IV push or Bolus
Administer IV infusion over no less than 120minutes via gravity feed, syringe type pump or infusion pump
Monitor serum Uric Acid Level |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Pegloticase is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Pegloticase is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Pegloticase
Back to top
Previous Drug Generic - Next Drug Generic